CD16+ monocytes control T-cell subset development in immune thrombocytopenia

Hui Zhong1, Weili Bao, Xiaojuan Li

  • 1Laboratory of Complement Biology, New York Blood Center, NY, USA.

Blood
|August 24, 2012
PubMed
Summary

In immune thrombocytopenia (ITP), expanded CD16(+) monocytes drive harmful Th1 cell responses, while suppressing beneficial regulatory T-cells (Tregs) and IL-17+ Th cells, revealing a key mechanism in ITP pathogenesis.